First Trust Advisors’s Roivant Sciences ROIV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Sell |
18,515
-2,119,679
| -99% | -$23.9M | ﹤0.01% | 2514 |
|
|
2025
Q1 | $21.6M | Sell |
2,138,194
-307,202
| -13% | -$3.1M | 0.02% | 847 |
|
|
2024
Q4 | $28.9M | Sell |
2,445,396
-561,219
| -19% | -$6.64M | 0.03% | 727 |
|
|
2024
Q3 | $34.7M | Sell |
3,006,615
-527
| -0% | -$6.08K | 0.03% | 623 |
|
|
2024
Q2 | $31.8M | Buy |
3,007,142
+1,290,584
| +75% | +$13.6M | 0.03% | 632 |
|
|
2024
Q1 | $18.1M | Sell |
1,716,558
-1,022,880
| -37% | -$10.8M | 0.02% | 836 |
|
|
2023
Q4 | $30.8M | Buy |
2,739,438
+2,227,192
| +435% | +$25M | 0.03% | 583 |
|
|
2023
Q3 | $5.98M | Buy |
512,246
+336,331
| +191% | +$3.93M | 0.01% | 1152 |
|
|
2023
Q2 | $1.77M | Sell |
175,915
-78,581
| -31% | -$792K | ﹤0.01% | 1773 |
|
|
2023
Q1 | $1.88M | Buy |
+254,496
| New | +$1.88M | ﹤0.01% | 1707 |
|